Try our beta test site
113 studies found for:    Northwestern AND Eyes
Show Display Options
Rank Status Study
1 Active, not recruiting Glaucoma Eye Drop Instillation: Impact of Education
Condition: Glaucoma, Open-Angle
Interventions: Other: Video education on proper eye drop instillation technique;   Other: Placebo video education on healthy eating tips
2 Completed Comparison of Brimonidine Purite, Dorzolamide, and Brinzolamide as Adjunctive Therapy to Prostaglandin Analogs
Conditions: Primary Open Angle Glaucoma;   Ocular Hypertension
Interventions: Drug: Brimonidine purite 0.15%;   Drug: Dorzolamide 2%;   Drug: Brinzolamide 1%
3 Active, not recruiting Cutaneous Prostaglandin Application: Nail Growth, Nail Brittleness, and Eye Pressure
Conditions: Nail Growth Cessation;   Intraocular Pressure
Interventions: Drug: Bimatoprost 0.01%;   Other: placebo: saline
4 Not yet recruiting Validation of a Newly Developed Liquid Jet Aesthesiometer
Condition: Ocular Surface Disease
Intervention:
5 Terminated
Has Results
Efficacy and Tolerability of Ramelteon in Patients With Rapid Eye Movement (REM) Behavior Disorder and Parkinsonism
Conditions: REM Behavior Disorder;   Parkinsonism
Interventions: Drug: Rozerem;   Drug: Placebo
6 Recruiting Comparison of Topical 0.15% Gancyclovir Gel Versus 0.3% Hypromellose Gel for the Treatment of Herpes Zoster Keratitis
Condition: Herpes Zoster Keratitis
Interventions: Drug: gancyclovir gel;   Drug: Hypromellose gel
7 Completed
Has Results
Development of Dermatology-related Quality of Life Assessment in Patients Treated With Epidermal Growth Factor Receptor (EGFR) Inhibitors
Condition: Skin Toxicities
Intervention: Other: Questionnaire
8 Terminated Hematopoietic Stem Cell Transplantation in Autoimmune-Related Retinopathy(ARRON)
Condition: Retinal Disease
Intervention: Biological: Hematopoietic stem cell transplantation.
9 Completed A Pilot Study of Needle Size and Pain Perception With Botulinum Toxin A Injections
Condition: Pain
Interventions: Procedure: 30-gauge needle;   Procedure: 32-gauge needle
10 Unknown  Evaluation of Centration of Intraocular Lens With Two Settings for Capsulorhexis With Femtosecond Laser
Condition: Capsulorhexis
Intervention: Procedure: capsulorhexis
11 Unknown  Do Blue-Blocking Lenses Block Blue Colour From Our Lives?
Condition: Blindness
Intervention: Procedure: cataract surgery
12 Completed Study of Medical Treatment of Low-Pressure (Normal Tension) Glaucoma
Condition: Glaucoma, Open Angle
Intervention: Drug: brimonidine, timolol
13 Unknown  A Safety Study of Hylan GF-20 to Treat Shoulder Osteoarthritis
Condition: Painful Shoulder Osteoarthritis
Intervention: Device: Hylan GF-20
14 Recruiting Hematopoietic Stem Cell Transplant in Devic's Disease
Condition: Devic's Disease
Intervention: Procedure: Hematopoietic stem cell transplantation
15 Completed VEGF Gene Transfer for Critical Limb Ischemia
Conditions: Critical Limb Ischemia;   Ischemia;   Leg Ulcer
Intervention: Genetic: pVGI.1 (VEGF-2)
16 Completed
Has Results
Age-Related Eye Disease Study 2 (AREDS2)
Conditions: Age-related Macular Degeneration;   Cataract
Interventions: Dietary Supplement: Lutein/zeaxanthin;   Dietary Supplement: DHA/EPA;   Drug: Lutein/zeaxanthin and DHA/EPA
17 Completed Evaluation of the Effectiveness and Safety of the Ulthera™ System for the Treatment of Wrinkles Around the Eyes
Condition: Periorbital Wrinkles
Intervention: Device: Ulthera™ System
18 Recruiting Treatment for CI-DME in Eyes With Very Good VA Study
Condition: Diabetic Macular Edema
Interventions: Procedure: Prompt Laser;   Drug: Prompt aflibercept;   Procedure: Deferred laser;   Drug: Deferred aflibercept
19 Active, not recruiting Cabozantinib-S-Malate Compared With Temozolomide or Dacarbazine in Treating Patients With Metastatic Melanoma of the Eye That Cannot Be Removed by Surgery
Conditions: Recurrent Uveal Melanoma;   Stage III Uveal Melanoma;   Stage IIIA Uveal Melanoma;   Stage IIIB Uveal Melanoma;   Stage IIIC Uveal Melanoma;   Stage IV Uveal Melanoma
Interventions: Drug: Cabozantinib S-malate;   Drug: Dacarbazine;   Other: Laboratory Biomarker Analysis;   Drug: Temozolomide
20 Terminated Macugen (Pegaptanib Sodium) Alone, Versus Macugen in Combination With PDT (Photodynamic Therapy) With Visudyne (Verteporfin) in Patients With Age-Related Macular Degeneration (AMD)
Condition: Age-Related Macular Degeneration
Interventions: Drug: Photodynamic Therapy (PDT) with Visudyne (verteporfin);   Drug: Macugen (pegaptanib sodium)

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.